REGENERON PHARMACEUTICALS INC COM STK USD0.001 earnings per share and revenue

0R2M earnings per share for the last quarter are 9.55 USD whereas the estimation was 10.17 USD which accounts for -6.11% surprise. Company revenue for the same period amounts to 3.15 B USD despite the estimated figure of 3.23 B USD. Estimated earnings per share for the next quarter are 10.61 USD, and revenue is expected to reach 3.37 B USD. Also watch annual changes over time to get a bigger picture of 0R2M earnings per share and revenue dynamics.